JP2010513901A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010513901A5 JP2010513901A5 JP2009542216A JP2009542216A JP2010513901A5 JP 2010513901 A5 JP2010513901 A5 JP 2010513901A5 JP 2009542216 A JP2009542216 A JP 2009542216A JP 2009542216 A JP2009542216 A JP 2009542216A JP 2010513901 A5 JP2010513901 A5 JP 2010513901A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- seq
- fragment
- hox
- homeodomain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0625321.5 | 2006-12-19 | ||
| GBGB0625321.5A GB0625321D0 (en) | 2006-12-19 | 2006-12-19 | Cancer biomarker |
| GB0719792.4 | 2007-10-10 | ||
| GBGB0719792.4A GB0719792D0 (en) | 2006-12-19 | 2007-10-10 | Cancer biomarkers |
| PCT/GB2007/004902 WO2008075056A1 (en) | 2006-12-19 | 2007-12-19 | Cancer biomarkers |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010513901A JP2010513901A (ja) | 2010-04-30 |
| JP2010513901A5 true JP2010513901A5 (enExample) | 2011-01-27 |
| JP5683108B2 JP5683108B2 (ja) | 2015-03-11 |
Family
ID=39265269
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009542216A Expired - Fee Related JP5683108B2 (ja) | 2006-12-19 | 2007-12-19 | 癌バイオマーカー |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US8460882B2 (enExample) |
| EP (1) | EP2115472B1 (enExample) |
| JP (1) | JP5683108B2 (enExample) |
| CN (1) | CN101675341B (enExample) |
| AU (1) | AU2007335999B2 (enExample) |
| BR (1) | BRPI0720371B8 (enExample) |
| CA (1) | CA2671939C (enExample) |
| CY (1) | CY1115178T1 (enExample) |
| DK (1) | DK2115472T3 (enExample) |
| ES (1) | ES2445185T3 (enExample) |
| GB (2) | GB0625321D0 (enExample) |
| IL (1) | IL199241A (enExample) |
| MX (1) | MX2009006378A (enExample) |
| NZ (1) | NZ577548A (enExample) |
| PL (1) | PL2115472T3 (enExample) |
| PT (1) | PT2115472E (enExample) |
| RU (1) | RU2460075C2 (enExample) |
| SI (1) | SI2115472T1 (enExample) |
| WO (1) | WO2008075056A1 (enExample) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8461126B2 (en) | 2005-10-14 | 2013-06-11 | Phigenix, Inc. | Targeting EN2, PAX2, and/or DEFB1 for treatment of prostate conditions |
| DE102006047617B4 (de) | 2006-10-09 | 2008-11-27 | Clariant International Limited | Verfahren zur Herstellung basischer (Meth)acrylamide |
| DE102008017216B4 (de) | 2008-04-04 | 2013-08-14 | Clariant International Ltd. | Kontinuierliches Verfahren zur Herstellung von Fettsäureamiden |
| GB0823445D0 (en) * | 2008-12-23 | 2009-01-28 | Univ Surrey | Biomarker |
| DE102009031059A1 (de) | 2009-06-30 | 2011-01-05 | Clariant International Ltd. | Vorrichtung zur kontinuierlichen Durchführung chemischer Reaktionen bei hohen Temperaturen |
| GB0912190D0 (en) * | 2009-07-13 | 2009-08-26 | Univ Surrey | Biomarker |
| GB0912175D0 (en) * | 2009-07-13 | 2009-08-26 | Univ Surrey | Biomarker |
| MX2012000541A (es) * | 2009-07-13 | 2012-03-14 | Univ Surrey | Peptidos, polipeptidos y secuencias de acidos nucleicos terapeuticos. |
| DE102009042523B4 (de) | 2009-09-22 | 2012-02-16 | Clariant International Ltd. | Vorrichtung und Verfahren zur kontinuierlichen Durchführung heterogen katalysierter chemischer Reaktionen bei hohen Temperaturen |
| DE102009042522A1 (de) | 2009-09-22 | 2011-04-07 | Clariant International Ltd. | Kontinuierliches Umesterungsverfahren |
| GB0921329D0 (en) * | 2009-12-04 | 2010-01-20 | Univ Surrey | Biomarker |
| DE102010056565A1 (de) | 2010-12-30 | 2012-07-05 | Clariant International Ltd. | Verfahren zur Modifizierung Hydroxylgruppen tragender Polymere |
| AU2012252426A1 (en) * | 2011-05-12 | 2013-11-28 | Noviogendix Research B.V. | Molecular markers in prostate cancer |
| US20140106363A1 (en) * | 2011-05-12 | 2014-04-17 | Noviogendix Research B.V. | Molecular markers in prostate cancer |
| CN103797120B (zh) * | 2011-09-16 | 2017-04-12 | 上海长海医院 | 前列腺癌的生物学标志物、治疗靶点及其用途 |
| MX2014006662A (es) * | 2011-12-05 | 2015-04-16 | Phigenix Inc | Direccionamiento de en2, pax2, y/o defb1 para tratamiento de afecciones de la próstata. |
| WO2014005138A1 (en) * | 2012-06-29 | 2014-01-03 | Kerschensteiner Daniel A | Colorimetric gelatinase assay |
| US10613087B2 (en) * | 2012-08-10 | 2020-04-07 | Analiza, Inc. | Methods and devices for analyzing species to determine diseases |
| WO2014179959A1 (en) * | 2013-05-09 | 2014-11-13 | The Procter & Gamble Company | Method and system for assessing health condition |
| WO2016102560A1 (en) * | 2014-12-23 | 2016-06-30 | The University Of Surrey | Glycosylated biomarker |
| KR101698654B1 (ko) * | 2014-12-24 | 2017-01-20 | 포항공과대학교 산학협력단 | En2에 특이적으로 결합하는 dna 압타머 및 이의 용도 |
| WO2016193110A1 (en) * | 2015-05-29 | 2016-12-08 | Koninklijke Philips N.V. | Methods of prostate cancer prognosis |
| EP3960195B1 (en) * | 2015-09-23 | 2025-01-08 | Centre national de la recherche scientifique | Engrailed for treatment of amyotrophic lateral sclerosis |
| CN106282347A (zh) * | 2016-08-17 | 2017-01-04 | 中南大学 | HoxC11作为生物标志物在制备肺腺癌的预诊断试剂中的应用 |
| US10508287B2 (en) | 2016-12-28 | 2019-12-17 | Guangzhou Institutes of Biomedicine and Health Chinese Academy of Sciences | Method for regenerating T cells and applications thereof |
| KR101777085B1 (ko) | 2017-02-23 | 2017-09-11 | 주식회사 성균바이오텍 | En2 단백질의 면역원성 단편 펩타이드 또는 이를 특이적으로 인식하는 항체 조성물 |
| KR101777254B1 (ko) | 2017-07-14 | 2017-09-13 | 주식회사 무진메디 | En2 단백질을 특이적으로 인식하는 특정 항원으로부터 얻어진 단클론 항체 또는 이를 함유하는 전립선암 진단용 조성물 |
| KR101777259B1 (ko) | 2017-07-14 | 2017-09-13 | 주식회사 무진메디 | En2 단백질을 특이적으로 인식하는 단클론 항체 또는 이를 함유하는 전립선암 진단용 조성물 |
| CN107894507A (zh) * | 2017-11-22 | 2018-04-10 | 南宁科城汇信息科技有限公司 | 一种发现和鉴定肝癌血清差异表达蛋白和验证标志物蛋白方法 |
| CN107727729A (zh) * | 2017-11-22 | 2018-02-23 | 南宁科城汇信息科技有限公司 | 一种oa候选标志物诊断模型的建立方法 |
| KR101923199B1 (ko) | 2018-04-25 | 2018-11-28 | 주식회사 무진메디 | 펩스타틴 a를 함유하는 소변 내 en2 진단용 조성물 |
| CN111363817B (zh) * | 2018-12-26 | 2024-02-02 | 广州康立明生物科技股份有限公司 | 基于hoxd12基因的肺癌诊断剂及试剂盒 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0996725A1 (en) * | 1997-06-27 | 2000-05-03 | Human Genome Sciences, Inc. | Human nk-3 related prostate specific gene-1 |
| RU2234942C2 (ru) * | 1998-07-14 | 2004-08-27 | Корикса Корпорейшн | Выделенный опухолевый полипептид предстательной железы и кодирующий его полинуклеотид |
| JP2002527758A (ja) * | 1998-10-19 | 2002-08-27 | ダイアデクスアス・インコーポレーテッド | 前立腺癌を診断、監視、病期分類、イメージング及び治療する方法 |
| EP1290442B1 (en) | 2000-05-30 | 2013-11-13 | Aarhus Universitet | An assay method for testing plant material for exposure to herbicides using biomarkers |
| WO2002000926A2 (en) * | 2000-06-30 | 2002-01-03 | Epigenomics Ag | Diagnosis of diseases associated with signal transduction |
| AU2001292718A1 (en) * | 2000-09-12 | 2002-03-26 | Transgenetics Incorporated | Microarrayed organization of transcription factor target genes |
| WO2002054936A2 (en) | 2000-12-24 | 2002-07-18 | Kohn, Kenneth, I. | A method for detecting biomarkers |
| US20040063216A1 (en) | 2000-12-24 | 2004-04-01 | Iser Lubocki | Method for detecting biomarkers |
| CA2439854A1 (en) * | 2001-03-01 | 2002-09-12 | Epigenomics Ag | Method for the development of gene panels for diagnostic and therapeutic purposes based on the expression and methylatoin status of the genes |
| US6949342B2 (en) * | 2001-12-21 | 2005-09-27 | Whitehead Institute For Biomedical Research | Prostate cancer diagnosis and outcome prediction by expression analysis |
| CA2469089A1 (en) * | 2003-07-08 | 2005-01-08 | Institut De Recherches Cliniques De Montreal | En-2 gene, disgnostic and therapeutic uses thereof |
| US20060014301A1 (en) | 2004-07-13 | 2006-01-19 | Power3 Medical Products, Inc. | Antibody-based system for detection of differential protein expression patterns |
| JP5745202B2 (ja) * | 2004-12-02 | 2015-07-08 | エピゲノミックス アクチェンゲゼルシャフト | 前立腺細胞増殖障害の予後に関連する遺伝子発現分析のための方法および核酸 |
| US9416422B2 (en) | 2005-02-18 | 2016-08-16 | Sloan-Kettering Institute For Cancer Research | Methods for detecting minimum residual disease |
-
2006
- 2006-12-19 GB GBGB0625321.5A patent/GB0625321D0/en not_active Ceased
-
2007
- 2007-10-10 GB GBGB0719792.4A patent/GB0719792D0/en not_active Ceased
- 2007-12-19 PL PL07848631T patent/PL2115472T3/pl unknown
- 2007-12-19 DK DK07848631.3T patent/DK2115472T3/da active
- 2007-12-19 CN CN200780051417.9A patent/CN101675341B/zh not_active Expired - Fee Related
- 2007-12-19 ES ES07848631.3T patent/ES2445185T3/es active Active
- 2007-12-19 NZ NZ577548A patent/NZ577548A/en not_active IP Right Cessation
- 2007-12-19 SI SI200731399T patent/SI2115472T1/sl unknown
- 2007-12-19 MX MX2009006378A patent/MX2009006378A/es active IP Right Grant
- 2007-12-19 US US12/518,708 patent/US8460882B2/en active Active
- 2007-12-19 WO PCT/GB2007/004902 patent/WO2008075056A1/en not_active Ceased
- 2007-12-19 JP JP2009542216A patent/JP5683108B2/ja not_active Expired - Fee Related
- 2007-12-19 AU AU2007335999A patent/AU2007335999B2/en not_active Ceased
- 2007-12-19 RU RU2009127774/15A patent/RU2460075C2/ru not_active IP Right Cessation
- 2007-12-19 BR BRPI0720371A patent/BRPI0720371B8/pt not_active IP Right Cessation
- 2007-12-19 CA CA2671939A patent/CA2671939C/en active Active
- 2007-12-19 PT PT78486313T patent/PT2115472E/pt unknown
- 2007-12-19 EP EP07848631.3A patent/EP2115472B1/en not_active Not-in-force
-
2009
- 2009-06-08 IL IL199241A patent/IL199241A/en active IP Right Grant
-
2014
- 2014-02-05 CY CY20141100091T patent/CY1115178T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010513901A5 (enExample) | ||
| RU2009127774A (ru) | Биомаркеры рака | |
| Hudler et al. | Proteomic approaches in biomarker discovery: new perspectives in cancer diagnostics | |
| US10345309B2 (en) | Biomarkers for gastric cancer and uses thereof | |
| WO2021076036A1 (en) | Apparatuses and methods for detection of pancreatic cancer | |
| JP4916441B2 (ja) | 結腸直腸腺腫及び／又は癌腫に対するバイオマーカーとしてのトランスサイレチンの使用；検出方法及び試験システム | |
| US20220268776A1 (en) | Biomarker panel for diagnosing pancreatic cancer and use thereof | |
| JP6774925B2 (ja) | 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療のための方法並びにそのキット | |
| CN104272112B (zh) | 用于帮助诊断中风的基于生物标记的方法和生物芯片 | |
| JP4516124B2 (ja) | 肝線維症の診断方法 | |
| EP2569451A1 (en) | Methods and devices for diagnosing alzheimers disease | |
| US20130210667A1 (en) | Biomarkers for Predicting Kidney and Glomerular Pathologies | |
| CN108841954A (zh) | 生物标志物在卵巢癌评估中的应用 | |
| KR20140115490A (ko) | 간암 진단용 바이오 마커 | |
| JP2016530545A (ja) | 卵巣がんに関するバイオマーカー | |
| AU2014247083B2 (en) | Methods and arrays for use in biomarker detection for prostate cancer | |
| JP2012526543A5 (enExample) | ||
| US20140248637A1 (en) | Composition for diagnosis of lung cancer and diagnosis kit of lung cancer | |
| KR20230113742A (ko) | 난소암의 검출 및 치료를 위한 방법 | |
| WO2020021026A1 (en) | Method of diagnosing asthma subtypes | |
| WO2023230584A1 (en) | Methods and systems for risk stratification and management of bladder cancer | |
| KR102346864B1 (ko) | 방광암 진단 또는 예후 분석용 바이오마커 조성물, 키트 및 이를 이용한 진단 방법 | |
| KR102136747B1 (ko) | 장형 위암의 예후 진단 마커 | |
| CN106093241A (zh) | 可用于检测喉癌的标志物及其用途 | |
| CN120442791B (zh) | 非功能性胰腺神经内分泌肿瘤预后标志物及其应用 |